Article Text

Download PDFPDF
Cytohistological diagnosis of pancreatic serous cystadenoma: a multimodal approach
  1. Michael Steel1,
  2. Samarth Rao2,
  3. Julie Ho3,
  4. Fergal Donnellan2,
  5. Hui-Min Yang1,
  6. David F Schaeffer1
  1. 1 Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada
  2. 2 Division of Gastroenterology, Vancouver General Hospital, Vancouver, British Columbia, Canada
  3. 3 Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
  1. Correspondence to Dr Michael Steel, Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC V5Z 1M9, Canada; smike{at}alumni.ubc.ca

Footnotes

  • Handling editor Runjan Chetty.

  • Contributors MS: data curation, formal analysis, writing—original draft, writing—review and editing. SR: data curation, writing—review and editing. JH: data curation, writing—review and editing. FD: supervision, data curation, writing—review and editing. H-MY: supervision, data curation, writing—review and editing. DFS: conceptualisation, data curation, supervision, methodology, writing—review and editing. FD, H-MY and DFS co-supervised this work.

  • Funding Partial funds for this project were received by the VGH and UBC Hospital Foundation.

  • Competing interests DFS reports consulting fees from Robarts Clinical Trials Inc., and the Provincial Health Services Authority, Vancouver, BC, as well as honoraria from Amgen.

  • Patient consent for publication Not required.

  • Ethics approval This manuscript has been read and approved by all authors, has not been published and is not under consideration for publication elsewhere. The study has been approved by the institutional research ethics board.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article or uploaded as online supplementary information.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Handling editor Runjan Chetty.

  • Contributors MS: data curation, formal analysis, writing—original draft, writing—review and editing. SR: data curation, writing—review and editing. JH: data curation, writing—review and editing. FD: supervision, data curation, writing—review and editing. H-MY: supervision, data curation, writing—review and editing. DFS: conceptualisation, data curation, supervision, methodology, writing—review and editing. FD, H-MY and DFS co-supervised this work.

  • Funding Partial funds for this project were received by the VGH and UBC Hospital Foundation.

  • Competing interests DFS reports consulting fees from Robarts Clinical Trials Inc., and the Provincial Health Services Authority, Vancouver, BC, as well as honoraria from Amgen.

  • Patient consent for publication Not required.

  • Ethics approval This manuscript has been read and approved by all authors, has not been published and is not under consideration for publication elsewhere. The study has been approved by the institutional research ethics board.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article or uploaded as online supplementary information.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.